Circulating levels of mannose-binding lectin (MBL) in age-related macular degeneration

ABSTRACT Purpose: To assess whether the serum levels of mannose-binding lectin of the lectin complement pathway are associated with age-related macular degeneration. Methods: Patients with age-related macular degeneration and age-matched controls underwent full ophthalmologic examination and optical...

ver descrição completa

Detalhes bibliográficos
Autor principal: Pradella,Fernando M. (author)
Outros Autores: Nisihara,Renato (author), Sato,Mario T. (author), Grandinetti,Alexandre A. (author), Novello,Sergio B. (author), Pires,Marcelo (author), Schebelski,Diego (author), Messias-Reason,Iara (author)
Formato: article
Idioma:eng
Publicado em: 2018
Assuntos:
Texto completo:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492018000200120
País:Brasil
Oai:oai:scielo:S0004-27492018000200120
Descrição
Resumo:ABSTRACT Purpose: To assess whether the serum levels of mannose-binding lectin of the lectin complement pathway are associated with age-related macular degeneration. Methods: Patients with age-related macular degeneration and age-matched controls underwent full ophthalmologic examination and optical coherence tomography. Using a time-resolved immunofluorometric assay, blood samples were evaluated to determine the serum mannose-binding lectin levels. Results: A total of 136 individuals were evaluated, including 68 patients with age-related macular degeneration (34 exudative and 34 nonexudative) and 68 age-matched controls. The median mannose-binding lectin level was 608 ng/mL (range, 30-3,415 ng/mL) in patients with age-related macular degeneration and 739 ng/mL (range, 30-6,039 ng/mL) in controls, with no difference between the groups. Additionally, the median mannose-binding lectin level was 476 ng/mL (range, 30-3,415 ng/mL) in exudative cases and 692 ng/mL (range, 30-2,587 ng/mL) in nonexudative cases. Conclusions: Serum mannose-binding lectin levels were not associated with age-related macular degeneration or with the exudative and nonexudative forms of the disease.